Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Complementary Medicine and Therapies
Published in: BMC Complementary Medicine and Therapies 1/2020

01-12-2020 | Pneumonia | Research article

Network pharmacology to dissect the mechanisms of Yinlai Decoction for pneumonia

Authors: Jingnan Xu, Chen Bai, Ling Huang, Tiegang Liu, Yuxiang Wan, Zian Zheng, Xueyan Ma, Fei Gao, He Yu, Xiaohong Gu

Published in: BMC Complementary Medicine and Therapies | Issue 1/2020

Login to get access

Abstract

Background

Pneumonia is a common respiratory disorder, which brings an enormous financial burden to the medical system. However, the current treatment options for pneumonia are limited because of drug resistance and side effects. Our previous study preliminarily confirmed that Yinlai Decoction (YD), a common prescription for pneumonia in clinical practice, can regulate the expression of inflammatory factors, but the mechanisms are unknown yet.

Methods

In our work, a method named network pharmacology was applied, which investigated the underlying mechanisms of herbs based on a variety of databases. We obtained bioactive ingredients of YD on TCMSP database and collected potential targets of these ingredients by target fishing. Then the pneumonia-related targets database was built by TTD, Drugbank, HPO, OMIM, and CTD. Based on the matching targets between YD and pneumonia, the PPI network was built by STRING to analyze the interactions among these targets and then input into Cytoscape for further topological analysis. DAVID and KEGG were utilized for GO and pathway enrichment analysis. Then rat model based on LPS stimulated pneumonia was used to verify the possible mechanism of YD in treating pneumonia.

Results

Sixty-eight active ingredients, 103 potential targets and 8 related pathways, which likely exert a number of effects, were identified. Three networks were constructed using Cytoscape, which were herb-component-network, YD-pneumonia target network, and herb-component-YD target-pneumonia network. YD was verified to treat LPS-induced pneumonia by regulating the inflammatory factor IL-6, which was a predicted target.

Conclusion

Network analysis indicated that YD could alleviate the symptoms and signs of pneumonia through regulating host immune inflammatory response, angiogenesis and vascular permeability, the barrier function of the airway epithelial cells, hormone releasing and cell growth, proliferation, and apoptosis.
Appendix
Available only for authorised users
Literature
1.
Lanks CW, Musani AI, Hsia DW. Community-acquired pneumonia and hospital-acquired pneumonia. Med Clin North Am. 2019;103(3):487–501.PubMedCrossRef
2.
3.
Jin Y, Yang H, Ji W, et al. Virology, epidemiology, pathogenesis, and control of COVID-19. Viruses. 2020;12(4):E372.PubMedCrossRef
4.
Taussig LM, M. Pediatric respiratory medicine. Second ed; 2008.
5.
Liu TG, et al. Influences of Yinlai Tang on sIgA, TNF-α and IL-10 in intestinal mucosal tissues of mice with dyspepsia combined with influenza virus infection. J Beijing Univ Tradit Chinese Med. 2014;37:86–9.
6.
Gao Y, et al. A network pharmacology approach to decipher the mechanisms of anti-depression of Xiaoyaosan formula. World J Tradit Chinese Med. 2018;4:147–62.CrossRef
7.
Gao K, et al. Effects of Qijian mixture on type 2 diabetes assessed by Metabonomics, gut microbiota and network pharmacology. Pharmacol Res. 2018;130:93–109.PubMedCrossRef
8.
Xiao S, et al. A visual analysis of network pharmacology research trends. World J Tradit Chinese Med. 2018;4:163–9.CrossRef
9.
Zhang SD, et al. Exploring the pathways and targets of Shexiang Baoxin pill for coronary heart disease through a network pharmacology approach. World J Tradit Chinese Med. 2018;4:137–46.CrossRef
10.
11.
Xu X, Zhang W, Huang C, Li Y, Yu H, Wang Y, Duan J, Ling Y. A Novel Chemometric Method for the Prediction of Human Oral Bioavailability. Int J Mol Sci. 2012;13:6964–82.
12.
Ano R, Kimura YM, Matsuno R, Ueno T, Akamatsu M. Relationships between structure and high-throughput screening permeability of peptide derivatives and related components with artificial membranes: application to prediction of caco-2 cell permeability. Bioorg Med Chem. 2004;12:257–64.PubMedCrossRef
13.
Ritchie TJ, Macdonald SJ. How drug-like are ‘ugly’ drugs: do drug-likeness metrics predict ADME behaviour in humans? Drug Discov Today. 2014;19(4):489–95.PubMedCrossRef
14.
Gong J, et al. ChemMapper: a versatile web server for exploring pharmacology and chemical structure association based on molecular 3D similarity method. Bioinformatics. 2013;29:1827.PubMedCrossRef
15.
Consortium UP. UniProt: a hub for protein information. Nucleic Acids Res. 2015;43:204–12.CrossRef
16.
Li YH, et al. Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics. Nucleic Acids Res. 2017;46:D1121–D1127.
17.
Law V, et al. DrugBank 4.0: shedding new light on drug metabolism. Nucleic Acids Res. 2014;42:1091–7.CrossRef
18.
19.
Hamosh A, et al. Online Mendelian inheritance in man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res. 2005;33:514–7.CrossRef
20.
Grondin CJ, Davis AP, Wiegers TC, Wiegers JA, Mattingly CJ. Accessing an expanded exposure science module at the comparative Toxicogenomics database. Environ Health Perspect. 2018;126:014501.PubMedPubMedCentralCrossRef
21.
Szklarczyk D, et al. STRING v10: protein–protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015;43:D447.PubMedCrossRef
22.
23.
Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2008;4:44.CrossRef
24.
Fatma M, Mohamed S. Enhanced anticancer activity and oral bioavailability of ellagic acid through encapsulation in biodegradable polymeric nanoparticles. Int J Nanomedicine. 2017;12:7405–17.CrossRef
25.
Lu T, et al. Plasma and urinary tanshinol from Salvia miltiorrhiza (Danshen) can be used as pharmacokinetic markers for cardiotonic pills, a cardiovascular herbal medicine. Drug Metabol Dispos Biol Fate Chem. 2008;36:1578.CrossRef
26.
27.
Jordán F, Liu WC, Memmott DJ. Topological keystone species: measures of positional importance in food webs. Oikos. 2006;112(3):535–46.CrossRef
28.
Holme P, Huss M, Jeong H. Subnetwork hierarchies of biochemical pathways. Bioinformatics. 2003;19(4):532–8.PubMedCrossRef
29.
Ma HW, Zeng AP. The connectivity structure, gian strong component and centrality of metabolic networks. Bioinformatics. 2003;19(11):1423–30.PubMedCrossRef
30.
Shohaib T, Shafique M, Dhanya N, Divakar MC. Importance of Flavonoides In therapeutics. Hygeia J Drugs Med. 2011;3(1):1–18.
31.
32.
Takagi R, et al. Wogonin attenuates ovalbumin antigen-induced Neutrophilic airway inflammation by inhibiting Th17 differentiation. Int J Inflamm. 2014;2014:571508.CrossRef
33.
Wakabayashi I, Yasui K. Wogonin inhibits inducible prostaglandin E 2 production in macrophages. Eur J Pharmacol. 2000;406:477–81.PubMedCrossRef
34.
García-Mediavilla V, et al. The anti-inflammatory flavones quercetin and kaempferol cause inhibition of inducible nitric oxide synthase, cyclooxygenase-2 and reactive C-protein, and down-regulation of the nuclear factor kappaB pathway in Chang liver cells. Eur J Pharmacol. 2007;557:221–9.PubMedCrossRef
35.
Zhong X, Kulis M, Guo R, Pons L, Burks AW. Streptococcus pneumoniae induced c-Jun-N-terminal kinase- and AP-1 -dependent IL-8 release by lung epithelial BEAS-2B cells. Respir Res. 2006;7:98.CrossRef
36.
Li XM, et al. Study on JNK/AP-1 signaling pathway of airway mucus hypersecretion of severe pneumonia under RSV infection. Eur Rev Med Pharmacol Sci. 2016;20:853.PubMed
37.
Yang Z, et al. Female resistance to pneumonia identifies lung macrophage nitric oxide synthase-3 as a therapeutic target. Elife. 2014;3.
38.
Fukunaga K, Kohli P, Bonnans C, Fredenburgh LE, Levy BD. Cyclooxygenase 2 plays a pivotal role in the resolution of acute lung injury. J Immunol. 2005;174:5033–9.PubMedCrossRef
39.
Zhang LN, et al. Protective effects of asiaticoside on septic lung injury in mice. Exp Toxicol Pathol Official J Gesellschaft Für Toxikologische Pathologie. 2011;63:519.CrossRef
40.
Chang C, Lee SO, Yeh S, Chang TM. Androgen receptor (AR) differential roles in hormone-related tumors including prostate, bladder, kidney, lung, breast and liver. Oncogene. 2014;33:3225–34.PubMedCrossRef
41.
Sun CH, et al. Effect of Acrolein on the protein expression of androgen receptor in male rat lung. Biol Reprod. 2012;87:251.CrossRef
42.
43.
Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science. 1990;249:1431–3.PubMedCrossRef
44.
Abrahams V, Abrahams M. V.M. the role of the nod-like receptor family in trophoblast innate immune responses. J. Reprod. Immunol. 88, 112-117. J Reprod Immunol. 2011;88:112–7.PubMedCrossRef
45.
Mangodt TC, et al. The role of Th17 and Treg responses in the pathogenesis of RSV infection. Pediatr Res. 2015;78:483–91.PubMedCrossRef
46.
Koff JL, Shao MX, Ueki IF, Nadel JA. Multiple TLRs activate EGFR via a signaling cascade to produce innate immune responses in airway epithelium. Am J Physiol Lung Cell Mol Physiol. 2008;294:L1068.PubMedCrossRef
47.
Mohammed KA, et al. Bacterial induction of pleural mesothelial monolayer barrier dysfunction. Am J Physiol Lung Cell Mol Physiol. 2001;281:119–25.CrossRef
48.
Van DFM, Coenjaerts F, Kimpen JL, Hoepelman AM, Geelen SP. Streptococcus pneumoniae induces secretion of vascular endothelial growth factor by human neutrophils. Infect Immun. 2000;68:4792–4.CrossRef
49.
Kanbay M, Kanbay A, Boyacioglu S. Helicobacter pylori infection as a possible risk factor for respiratory system disease: a review of the literature. Respir Med. 2007;101:203–9.PubMedCrossRef
50.
Wang D, et al. A new prenylated flavonoid i nduces g0/g1 arrest and apoptosis through p38/jnk mapk pathways in human hepatocellular carcinoma cells. Sci Rep. 2017;7(1):5736.PubMedPubMedCentralCrossRef
51.
Karin W, Nam V, Dimitris K, Norbert B. Inflammatory and catabolic signalling in intervertebral discs: the roles of NF-κB and MAP kinases. Eur Cells Mater. 2012;23:103.
52.
Gibbs JD, et al. Cell cycle arrest by transforming growth factor β1 enhances replication of respiratory syncytial virus in lung epithelial cells. J Virol. 2009;83:12424–31.PubMedPubMedCentralCrossRef
Metadata
Title
Network pharmacology to dissect the mechanisms of Yinlai Decoction for pneumonia
Authors
Jingnan Xu
Chen Bai
Ling Huang
Tiegang Liu
Yuxiang Wan
Zian Zheng
Xueyan Ma
Fei Gao
He Yu
Xiaohong Gu
Publication date
01-12-2020
Publisher
BioMed Central
Keyword
Pneumonia
Published in
BMC Complementary Medicine and Therapies / Issue 1/2020
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-020-02954-z

Other articles of this Issue 1/2020

BMC Complementary Medicine and Therapies 1/2020 Go to the issue

Research article

4-Hydroxyisoleucine relieves inflammation through iRhom2-dependent pathway in co-cultured macrophages and adipocytes with LPS stimulation

Research article

The effects of add-on self-care education on quality of life and fatigue in gastrointestinal cancer patients undergoing chemotherapy

Research article

Online yoga to reduce post traumatic stress in women who have experienced stillbirth: a randomized control feasibility trial

Research article

A network pharmacology study on analgesic mechanism of Yuanhu-Baizhi herb pair

Research article

Germacrone exerts anti-cancer effects on gastric cancer through induction of cell cycle arrest and promotion of apoptosis

Research article

Inhibitory effect of novel Eugenol Tosylate Congeners on pathogenicity of Candida albicans